Watchlist Price Alert

Poseida Therapeutics Inc. (PSTX)

NASDAQ: PSTX · Real-Time Price · USD

9.50

0.00 (0.00%)

At close: Jan 07, 2025, 9:00 PM

Poseida Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	64.7M	130.36M	31.24K	n/a	n/a	n/a	2.98M	9.77M
Cost of Revenue	156.77M	5.17M	4.55M	2.59M	1.19M	689K	n/a	n/a
Gross Profit	-92.07M	125.19M	-4.52M	-2.59M	-1.19M	-689K	2.98M	9.77M
Operating Income	-129.5M	-59.95M	-141.41K	-126.55K	-85.53M	-41.99M	-19.67M	-5.45M
Interest Income	n/a	6.37M	3.36M	3.51M	1.55M	n/a	n/a	n/a
Pretax Income	-123.32M	-63.46M	-124.97K	-129.78K	-86.53M	-44.61M	-20.19M	-5.34M
Net Income	-123.43M	-64M	4.4M	2.45M	-92.64M	-44.4M	-19.66M	-4.58M
Selling & General & Admin	37.44M	37.54M	35.91K	23.03K	18.46M	9.67M	5.48M	5.13M
Research & Development	156.77M	152.9M	136.73K	103.52K	60.39M	30.88M	19.1M	9.86M
Other Expenses	n/a	2.86M	19.8K	280.00	2.56M	-821K	37K	n/a
Operating Expenses	194.21M	190.44M	172.65K	126.55K	78.85M	40.56M	24.58M	15M
Interest Expense	8.67M	6.37M	3.36K	3.51K	3.55M	1.8M	558K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-220K
Cost & Expenses	179.35M	190.44M	172.65K	126.55K	78.85M	40.56M	24.58M	15.22M
Income Tax Expense	107K	544K	-4.53M	-2.58M	6.11M	-202K	-527K	-765K
Shares Outstanding (Basic)	90.19M	71.91M	62.18M	36M	39.73M	35.93M	39.73M	59.32M
Shares Outstanding (Diluted)	90.19M	71.95M	62.24M	36M	39.73M	35.93M	39.73M	59.32M
EPS (Basic)	-1.37	-0.89	0.07	0.07	-2.33	-1.24	-0.49	-0.08
EPS (Diluted)	-1.37	-0.89	0.07	0.07	-2.33	-1.24	-0.49	-0.08
EBITDA	-109.04M	-54.77M	-117.06M	-145.48M	-91.68M	-45.12M	-20.88M	-5.12M
EBIT	-114.65M	-57.09M	-121.62M	-148.07M	-92.87M	-45.81M	-19.63M	-5.34M
Depreciation & Amortization	5.61M	5.17M	4.55M	2.59M	1.19M	689K	676K	220K